NURIX THERAPEUTICS, INC.: capex
| Value | {"amount": 2981000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2025-12-01 – 2026-05-31 |
| Status | current |
| Entity | NURIX THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:43:23.910780+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/6ff93ec0-b52e-4eda-812a-74907ba47237
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001549595-26-000040 · Open the official SEC filing →Retrieved: 2026-08-19T15:43:23.910780+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001549595/capex/2026-05-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/6ff93ec0-b52e-4eda-812a-74907ba47237
History
- no predecessors — first report